4.6 Article

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019

Carolina Garcia-Vidal et al.

Summary: Hospitalized patients with COVID-19 experiencing respiratory symptoms have different complications, which can be identified by analytical patterns. Personalized treatment decisions can decrease early mortality, while increasing age and therapeutic effort limitation are associated with higher mortality.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019

Reed Magleby et al.

Summary: This study found that the admission SARS-CoV-2 viral load among hospitalized patients with COVID-19 is independently associated with the risk of intubation and in-hospital mortality, with higher viral loads linked to increased mortality and intubation risk.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Chanu Rhee et al.

Summary: SARS-CoV-2 is most contagious around symptom onset, with infectivity rapidly decreasing to near-zero afterwards; mild-moderately ill patients can safely discontinue isolation after about 10 days, while severely-critically ill and immunocompromised patients may need 15 days. The longest duration associated with replication-competent virus is 20 days.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Serum as Predictor of Severe Outcome in Coronavirus Disease 2019: A Retrospective Cohort Study

Karl Hagman et al.

Summary: Detection of SARS-CoV-2 RNA in serum at hospital admission is associated with a higher risk of progression to critical disease and death in COVID-19 patients. Positive results indicate a poorer outcome.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

Chronological Changes of Viral Shedding in Adult Inpatients With COVID-19 in Wuhan, China

Jing-Tao Huang et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Critical Care Medicine

SARS-CoV-2 viral load predicts COVID-19 mortality

Elisabet Pujadas et al.

LANCET RESPIRATORY MEDICINE (2020)

Review Infectious Diseases

A Narrative Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19

Sonia N. Rao et al.

INFECTIOUS DISEASES AND THERAPY (2020)

Article Public, Environmental & Occupational Health

Is Higher Viral Load in SARS-CoV-2 Associated with Death?

Klinger Soares Faico-Filho et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Editorial Material Medicine, General & Internal

Therapy for Early COVID-19 A Critical Need

Peter S. Kim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Medicine, General & Internal

Artificial intelligence to support clinical decision-making processes

Carolina Garcia-Vidal et al.

EBIOMEDICINE (2019)